PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMP... von Kolbin, A. S., Vilum, I. A., Proskurin, М. A., Balykina, Yu. E.

Volltext

Pharmacoeconomic characteristics of ixabepilone (Ixempra) monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, tax... von Kolbin, А.S., Mosikyan, А.A., Kurilev, А.A., Balykina, Yu.E., Proskurin, М.A.

Volltext

Health economic evaluation of risdiplam in patients with spinal muscular atrophy von Kolbin, А. S., Kurylev, А. А., Balykina, Yu. Е., Proskurin, М. А., Mishinova, S. А.

Volltext

О нижней границе вероятности правильной классификации наблюдений von Арбеков, И М, Arbekov, I M, Проскурин, Г В, Proskurin, G V

Volltext